● Recruiting

Study of Inhaled ARO-RAGE in Allergen-induced Mild Asthma

Condition: Asthma · Sponsor: Arrowhead Pharmaceuticals

PhasePhase 2

Planned participants36

Who can joinAll sexes, 18 Years to 65 Years

Healthy volunteersNo

About this study

The purpose of this study is to evaluate the impact of inhaled ARO-RAGE on the late asthmatic response (LAR) following an inhaled allergen challenge in participants with mild atopic asthma.

This description comes directly from the study's public registry record.

Talk to the study team

Medical Monitor · 626-304-3400 · ARORAGE-2001@arrowheadpharma.com

Always discuss trial participation with your own doctor first.

Locations (5)

Research Site 1	Vancouver, British Columbia, Canada	Recruiting
Research Site 2	Calgary, Canada	Recruiting
Research Site 3	Edmonton, Canada	Recruiting
Research Site 5	Hamilton, Canada	Recruiting
Research Site 4	Saskatoon, Canada	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07241546